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SUMMARY The presence of plasma cells in melanocytic lesions has 
been considered in literature as a sign of concern, when evaluated 
in the appropriate context. Plasma cells have been evaluated in halo 
nevus, but they are not frequently reported in non-halo common 
acquired nevus. Our claim was to study how common and frequent 
plasma cells are in the latter type of nevi. Therefore, we examined 
280 of these nevi and selected the cases with an inflammatory 
infiltrate, even if mild. We then looked for plasma cells in the 
inflammatory infiltrate in the hematoxylin-eosin routine sections and 
selected 17 cases in which plasma cells (even if only occasional) 
could be found in the hematoxylin-eosin staining. Out of these 17, 
plasma cells were easily found in four cases, which were then further 
studied with immunohistochemistry for epithelial membrane antigen. 
The percentage of plasma cells varied in these four cases from 0.5% 
to 7%. No relation between the amount of plasma cells and either 
the location of the nevus or the location of the inflammatory infiltrate 
could be established. We conclude that the main point of this study 
is not to trust the presence of plasma cells as a solid criterion on its 
own, when evaluating a melanocytic lesion.
KeY woRdS: plasma cell, melanocytic nevus, epithelial membrane 
antigen
IntRodUCtIon
The presence of plasma cells in the inflamma-
tory infiltrate of a melanocytic lesion is not a trivial 
finding and, depending on the context, can be 
quite meaningful. When found in a melanoma, for 
instance, plasma cells have been demonstrated to 
have a prognostic value (1-5): an infiltrate rich in 
plasma cells correlates adversely with the possi-
bility of metastasis. 
Moreover, plasma cells have also been sug-
gested as a diagnostic clue in the differential diag-
nosis between benign and malignant melanocytic 
lesions: halo nevus usually shows only a discrete 
number of plasma cells (6,7). Thus, a melanocytic 
lesion which looks like a halo-nevus but in which 
plasma cells are numerous should raise concern 
for melanoma. On the contrary, a low amount of 
plasma cells does not necessarily exclude mela-
noma: the inflammatory infiltrate that is evidenced 
in melanoma regression usually has a few plasma 
cells (8). 
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Plasma cells can also be of diagnostic value 
in the differential diagnosis between desmoplastic 
Spitz nevus and desmoplastic melanoma; the for-
mer nearly always lacks plasma cells (9).
We wanted to study something which is hardly 
ever mentioned in the literature: how abundant 
plasma cells are in the inflammatory infiltrate of 
innocent-looking acquired non-halo nevi. We also 
wanted to investigate if plasma cells were distrib-
uted according to any preferential pattern (band, 
perifollicular, etc.).
MAteRIAl And MethodS
We examined 280 melanocytic nevi of patients 
who did not have a clinical halo phenomenon. The 
nevi were classified according to the eponymic 
designation that had been previously proposed in 
the literature (10-12).
From these, we selected those with an inflam-
matory infiltrate, even if mild. We then looked for 
plasma cells in the inflammatory infiltrate in the 
hematoxylin-eosin routine sections and selected 
those cases in which plasma cells (even if only 
occasional) could be found in the hematoxylin-
eosin staining. The cases in which plasma cells 
were more easily found, were also studied by 
immunohistochemistry with epithelial membrane 
antibody (DakoCytomation, monoclonal mouse 
antihuman, isotype Ig2a, kappa, immunogen: fat 
globule membranes from human milk; clone E29, 
code N1504) in order to quantify better the amount 
of plasma cells. The percentage of plasma cells in 
relation to the rest of the inflammatory cells was 
evaluated in all cases in which immunostaining 
was performed.
ReSUltS
From the 280 nevi examined, we found some 
inflammatory infiltrate (even if mild) in 41 (14.64%) 
cases. Of these, plasma cells were occasional in 
17 cases in the hematoxylin-eosin slides. Table 1 
shows clinical details of these 17 cases, with the 
location and histologic type of the nevi. In these 17 
cases, the distribution of the infiltrate was mainly 
perivascular superficial in 11 cases, perivascular 
superficial and deep in 1 case, perifollicular in 3 
cases, peri-infundibular in 1 case, and peri-infun-
dibular plus perifollicular in 1 case. 
In four cases (cases 1, 2, 3 and 5), plasma cells 
were found more easily with the hematoxylin-eosin 
staining (Fig. 2). In these latter four cases, the im-
munohistochemical study was useful in standing 
out the plasma cells (Fig. 2). In the total amount 
of inflammatory cells, plasma cells accounted for 
a percentage that varied between 0.5% (case 3) 
and 7% (case 5) (Table 1, Fig. 3).









Percentage of plasma 
cells in the infiltrate
1 Female 70 Nose Miescher Perifollicular & peri-
infundibular
1
2 Female 68 Neck Unna Perifollicular 5
3 Female 35 Right leg Clark Perivascular superficial 0.5
4 Female 46 Back Clark Perivascular superficial NS
5 Female 46 Nose Miescher Perivascular superficial 7
6 Female 25 Back Miescher Perivascular superficial NS
7 Male 32 Back Clark Perivascular superficial NS
8 Female 24 Back Clark Perivascular superficial NS
9 Female 48 Neck Unna Perifollicular NS
10 Male 72 Face Unna Perifollicular NS
11 Male 59 Back Clark Perivascular superficial NS
12 Female 29 Abdomen Clark Perivascular superficial NS
13 Female 33 Retroauricular area Unna Perivascular superficial NS
14 Female 51 Face Unna Perivascular superficial 
& deep
NS
15 Female 49 Face Miescher Periinfundibular NS
16 Female 59 Face Miescher Perivascular superficial NS
17 Male 26 Scalp Miescher Perivascular superficial NS
NS=not studied
Fernandez-Flores	      Acta Dermatovenerol Croat
Plasma cell infiltrate in melanocytic nevus   2008;16(3):158-163
160
dISCUSSIon
The presence of plasma cells in melanocytic 
lesions has been considered as a useful criterion 
in the differential diagnosis between malignancy 
and benignancy in the appropriate context. For 
instance, their presence in what looks like a des-
moplastic Spitz nevus should alert the possibility 
of a desmoplastic melanoma (9).
Figure 1. Case 2 in which a mild inflammatory 
infiltrate was seen in a perifollicular location (top, 
arrow), but mixed with nevus cells in the deep re-
ticular dermis (middle). When examined at high 
magnification, plasma cells were easily identified 
with routine hematoxylin-eosin staining.
It has also been mentioned how plasma cells 
are only occasionally found in the inflammatory 
infiltrate of a halo nevus (6). This was later con-
firmed at the ultrastructural level (7). Even when 
halo nevi are studied in their several evolutional 
stages, neither plasma cells nor B-cells in gen-
eral seem to be a main component of the infiltrate 
(13).
On the other hand, plasma cells can be numer-
ous in the inflammatory infiltrate accompanying 
melanoma and this fact has been found to have an 
adverse prognostic value (1-5): whenever a heavy 
infiltrate of plasma cells is present in a melanoma, 
Figure 2. Immunostaining for epithelial membrane 
antigen in case 2 showing a perifollicular distribu-
tion of the inflammatory infiltrate (F, follicle). The 
technique was useful in standing out numerous 
plasma cells in the infiltrate, in the proximity of ne-
vus cells (N).
Figure 3. Immunostaining for epithelial membrane 
antigen in case 5 showing a focus rich in plasma 
cells close to nevus cells (N).
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the possibility of lymph node metastasis should be 
considered. Therefore, if a large amount of plasma 
cells are seen in a lesion that looks like a halo ne-
vus, the possibility of melanoma should be consid-
ered. This is especially important in cases of halo 
Spitz nevus, where epitheloid melanocytes can al-
ready be a concern for malignancy. Nevertheless, 
plasma cells are absent in a halo Spitz nevus, un-
less there is a traumatic epidermal defect (9). 
In spite of this diagnostic use of plasma cells, 
studies investigating them in the inflammatory in-
filtrate of halo nevus are not so frequent (6,7), and 
the ones investigating these cells in common ac-
quired nevus are even rarer (14). 
Our results indicated that on some occasions 
plasma cells could be present and easily found in 
common, innocent-looking nevi. A similar result 
was reported in conjunctival nevi, although mainly 
in patients who presented a history of allergic dis-
ease (14). 
We found no explanation for the conspicuous 
plasma cells in these four cases, since the fea-
tures of the four were not peculiar: the location of 
the lesion, the histological type of nevus or the lo-
cation of the infiltrate were not different in these 
four cases from some other examples in the rest of 
the cases in our series. The location of the lesion 
could suggest the possibility of trauma in some 
cases (the neck or nose), but not easily in others 
(back). Again, among our cases, there were many 
examples of nevi on the face and nose with only 
very few and occasional plasma cells. 
Therefore, in our opinion, the main point of 
our findings is that the presence of plasma cells 
should not necessarily make one think of malig-
nancy, even if the other morphological features 
of the melanocytic lesion evaluated point towards 
benignancy.
The reason why plasma cells seem to be 
more common in melanoma than in nevi has not 
yet been elucidated. Nevertheless, it might have 
something to do with the fact that the inflamma-
tory infiltrate, according to some, could be just an 
epiphenomenon in halo nevus (i.e. not necessar-
ily for the nevus clearance) (15). It would, on the 
contrary, represent an immune response against 
melanoma cells. Nevertheless, this interpretation 
is not a consensus (13). For some, the inflamma-
tory infiltrate plays a crucial role in the regression 
of the halo nevus (16,17), but it should be noted 
that such a role is mainly played by T-cells and 
not by B-cells (13,18,19). In melanoma, on the 
contrary, it is mostly agreed that the presence of 
a B-cell infiltrate would be the result of sensitiza-
tion of the lymphocytes which have travelled to the 
skin from the lymph nodes, where they had been 
in contact with the metastatic melanocytes (15). 
This explains the observations reported in the past 
on the predictability of nodal metastasis, based on 
the presence of plasma cells in the inflammatory 
infiltrate of melanoma (4,5). It would also explain 
the paradox on how a prominent inflammatory in-
filtrate in a melanoma is not correlated with a bet-
ter prognosis (20), opposite to what happens in 
many other tumors (21,22). 
A therapeutic proof of this sensitization has 
been obtained in patients with metastatic mela-
noma who were vaccinated with autologous mela-
noma cells. Although the resected metastatic nod-
ules, previous to vaccination, presented a minimal 
inflammatory infiltrate, a dense inflammatory infil-
trate with plasma cells was found in metastatic le-
sions resected after the vaccination (23).
This sensitization has nothing to do with the re-
ported presence of “plasmacytoid cells” in some 
inflammatory infiltrates induced by topical treat-
ments of melanocytic lesions (24): plasmacytoid 
cells are not related to plasma cells; the former 
are CD4+ cells (17,24) which are able to produce 
large amounts of type 1-interferons (25-30). 
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